SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-20-036495
Filing Date
2020-11-12
Accepted
2020-11-12 15:22:10
Documents
1
Period of Report
2020-11-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2129
  Complete submission text file 0001213900-20-036495.txt   3571
Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARS.COM, 300 S. RIVERSIDE PLAZA SUITE 1000 CHICAGO IL 60606
Business Address
McGovern Jr. Donald A. (Reporting) CIK: 0001706276 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38105 | Film No.: 201306236